Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)

CYCC

NSC
Cyclacel Pharmaceuticals Inc.
HealthcareBiotechnology
Watchlist:
Last updated: Thursday 3rd July 2025
0.25
-0.09 (-26.29%)
Prev Close:0.3363
Open:0.29
Bid:0.2493
Ask:0.2498
52 Week Range
0.23
39.84
Volume:1,481,818
Mkt Cap:7 M
Price Target
$0.29
+17.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Technicals

Technical Oscillators
Volatility Metrics

Profitability

Financials

Financial Statements

CYCC - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Accretion On Preferred Stock135000.0
Accrued Preferred Stock Dividends201000.0201000.0201000.04 M201000.0201000.07 M200000.0201000.0
Basic EPS From Continuing Operations-2.09-456.0-513.6-820.8-9360.0-16800.0
Basic EPS Total-2.09-456.0-513.6-820.8-9360.0-16800.0
Basic Weighted Shares Outstanding5 M46898.037192.015139.03400.02519.01589.0713.0565.0
Depreciation20000.0-20000.0-29000.0-32 M
Depreciation And Amortization20000.0-20000.0-29000.0-32 M
Diluted EPS Total-2.09-456.0-513.6-820.8-2352.0-2976.0-9360.0-16800.0
Diluted Normalized Net Income/share-2.09-456.0-513.6
Diluted Weighted Shares Outstanding5 M46898.037192.03329.02898.01589.0713.0
General And Administrative Expense5 M7 M7 M7 M6 M-300000.0-400000.05 M6 M
Gross Operating Profit43000.0420000.0843000.02 M
Income Before Tax-12 M-26 M-26 M-23 M-10 M-9 M-9 M-8 M-14 M-16 M
Income Taxes-782000.0-3 M-5 M-4 M-1 M-1 M-1 M-4 M-2 M-2 M
Interest Income12000.0266000.0210000.016000.042000.0224000.0331000.0118000.037000.0-42000.0
Misc Other Special Charges52000.050000.01 M144000.0891000.0231000.0832000.0949000.066000.094000.0
Net Income From Total Operations-11 M-23 M-21 M-18 M-8 M-8 M-7 M-8 M-14 M-14 M
Net Income Common Stockholders-11 M-23 M-21 M-19 M-12 M-8 M-7 M-16 M-14 M-15 M
Net Income Continuous Operations-11 M-23 M-21 M-19 M-8 M-8 M-7 M-8 M-14 M-14 M
Net Non Operating Interest Income Expense12000.0266000.0210000.016000.042000.0224000.0331000.0118000.037000.0-42000.0
Normalized Income-13 M-27 M
Operating Income-12 M-25 M-28 M-23 M-11 M-10 M-10 M-9 M-14 M-16 M
Operating Income Before Depreciation (EBITDA)-12 M-26 M-28 M-22 M-11 M-9 M-9 M-8 M-14 M-16 M
Operating Expense12 M26 M28 M23 M11 M10 M10 M9 M15 M18 M
Other Income Net-52000.0-50000.02 M-144000.0-891000.0-231000.0-832000.0-949000.0-66000.0-94000.0
Other Gand A5 M7 M7 M7 M6 M-300000.0-400000.05 M6 M
Other Operating Expenses12 M26 M62528.0200000.0400000.0
Otherunder Preferred Stock Dividend201000.0201000.0201000.04 M201000.0201000.07 M200000.0201000.0
Preferred Stock Dividends201000.0201000.0201000.04 M201000.0201000.07 M200000.0201000.0
Rent And Landing Fees-400000.0-500000.0
Research & Development Expense7 M19 M20 M15 M5 M5 M4 M4 M9 M12 M
Research Expense7 M19 M20 M15 M5 M5 M4 M4 M9 M12 M
Salaries And Wages592000.01 M-466000.0-331000.0
Selling Gen & Administrative Expense5 M7 M7 M7 M6 M5 M5 M5 M6 M6 M
Selling And Marketing Expense5 M5 M6 M
Selling Expense5 M5 M6 M
Total Income Available For Interest Expense (EBIT)-12 M-26 M-28 M-22 M-11 M-9 M-9 M-8 M-14 M-16 M
Total Common Shares Outstanding82391.052246.041638.029598.03583.03583.02499.0890.0617.0
Total Net Income-11 M-23 M-21 M-18 M-8 M-8 M-7 M-8 M-14 M-14 M
Total Ordinary Shares22 M22 M22 M22 M22 M22 M22 M22 M22 M22 M
Total Revenues43000.0420000.0150000.0843000.02 M
Total Expenses12 M26 M28 M23 M11 M10 M10 M9 M15 M18 M
Total Revenue43000.0420000.0150000.0843000.02 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader